scholarly journals Abstract 1883: Ovarian cancer cells overcome the cytotoxic effect of cisplatin by hyper activating CCR9-mediated signaling in response to cisplatin

Author(s):  
Hina Mir ◽  
Neeraj Kapur ◽  
Shailesh Singh
2012 ◽  
Vol 27 (4) ◽  
pp. 259-266 ◽  
Author(s):  
Kang Cao ◽  
Jing Yang ◽  
Chao Lin ◽  
Bao-ning Wang ◽  
Yuan Yang ◽  
...  

2020 ◽  
Vol 19 (7) ◽  
pp. 1417-1422
Author(s):  
Rao Zhiwei ◽  
Xia Songbai ◽  
Han Qi

Purpose: To assess the cytotoxic effect of 5, 7-dihalo-8-quinolinol complex (DHQ) on ovarian cancer cells, and the mechanism of action involved.Methods: DHQ-mediated changes in cell viability were determined using MTT assay, while apoptosis was analyzed with flow cytometry. The effect of DHQ on cell migration was determined using inverted microscopy, while its effect on invasiveness was assessed with Giemsa dyeing. FACS Caliburinstrumentation was employed for analyzing the effect of DHQ on the cell cycle. The protein expressions of Wip1 and P53 were assayed by western blotting.Results: DHQ induced cytotoxicity against A2780 and OVCAR 3 cells in the concentration range of 0.25 - 12 μM (p < 0.05). In A2780 and OVCAR 3 cells, treatment with 12 μMDHQ resulted in 69.34 and 65.46 % apoptosis, respectively. The migratory potential and invasiveness of A2780 and OVCAR3 cells were significantly decreased by 12 μMDHQ, relative to untreated cells (p < 0.05). Moreover, treatment with 12 μMDHQ arrested cell cycle at G1/G0 phase in A2780 and OVCAR3 cells, but downregulated the protein expressions of Wip1 expression in A2780 and OVCAR3 cells.Conclusion: DHQ exerts cytotoxic effect on ovarian cancer cell growth via arrest of cell cycle and activation of apoptosis. Moreover, DHQ inhibits the migratory and invasive abilities of the cells. Thus, DHQ is a potential drug candidate for the management of ovarian cancer. Keywords: 5,7-Dihalo-8-quinolinol complex, Ovarian cancer, Cytotoxicity, Apoptosis, Invasiveness, Migration, Cell cycle


2007 ◽  
Vol 77 (Suppl_1) ◽  
pp. 157-158
Author(s):  
Kathleen Austin ◽  
Edward Van Kirk ◽  
N. Sreejayan ◽  
William Murdoch ◽  
Brenda Alexander

2012 ◽  
Vol 48 (2) ◽  
pp. 55-63 ◽  
Author(s):  
M. Muller ◽  
M. Chérel ◽  
P.-F. Dupré ◽  
S. Gouard ◽  
M. Collet ◽  
...  

FEBS Journal ◽  
2010 ◽  
Vol 277 (24) ◽  
pp. 5146-5160 ◽  
Author(s):  
Stephanie Jutras ◽  
Magdalena Bachvarova ◽  
Mamadou Keita ◽  
Jean-Loup Bascands ◽  
Anne-Marie Mes-Masson ◽  
...  

2011 ◽  
Vol 46 (3) ◽  
pp. 139-147 ◽  
Author(s):  
Matthieu Muller ◽  
Michel Chérel ◽  
Pierre-François Dupré ◽  
Sébastien Gouard ◽  
Michel Collet ◽  
...  

Cancers ◽  
2020 ◽  
Vol 12 (2) ◽  
pp. 476 ◽  
Author(s):  
Alina Bisag ◽  
Cristiana Bucci ◽  
Sara Coluccelli ◽  
Giulia Girolimetti ◽  
Romolo Laurita ◽  
...  

Epithelial Ovarian Cancer (EOC) is one of the leading causes of cancer-related deaths among women and is characterized by the diffusion of nodules or plaques from the ovary to the peritoneal surfaces. Conventional therapeutic options cannot eradicate the disease and show low efficacy against resistant tumor subclones. The treatment of liquids via cold atmospheric pressure plasma enables the production of plasma-activated liquids (PALs) containing reactive oxygen and nitrogen species (RONS) with selective anticancer activity. Thus, the delivery of RONS to cancer tissues by intraperitoneal washing with PALs might be an innovative strategy for the treatment of EOC. In this work, plasma-activated Ringer’s Lactate solution (PA-RL) was produced by exposing a liquid substrate to a multiwire plasma source. Subsequently, PA-RL dilutions are used for the treatment of EOC, non-cancer and fibroblast cell lines, revealing a selectivity of PA-RL, which induces a significantly higher cytotoxic effect in EOC with respect to non-cancer cells.


Sign in / Sign up

Export Citation Format

Share Document